Causes, clinical manifestations, and treatment efficacy of recurrent pulmonary tuberculosis.

Objective: Within the contemporary medical and scientific community, research aimed at identifying the causes, analysing the clinical manifestations, and evaluating the effectiveness of treatment for recurrent pulmonary tuberculosis has become particularly relevant considering an increasing number of cases of Mycobacterium tuberculosis (MTB) resistance to anti-tuberculosis drugs (ATDs). Methods: The study encompasses an analysis of the primary factors contributing to recurrences, including socio-economic conditions, alcohol abuse, comorbidities, incarceration, human immunodeficiency virus (HIV), and others. The morbidity structure is examined, key clinical manifestations and complications of recurrent tuberculosis are identified, and the efficacy of chemotherapy is assessed depending on the drug resistance of MTB. Statistical analysis demonstrated the percentage of successful cessation of bacterial excretion and cavity closure, as well as treatment outcomes. Results: Thus, the study represents a comprehensive analysis aimed at improving the understanding of the dynamics and factors of recurrent pulmonary tuberculosis, which is crucial for the development of more effective treatment. Conclusions: The study holds practical value for healthcare professionals, as it provides data and observations that can be utilised to enhance strategies for the diagnosis, treatment, and prevention of the disease, thereby contributing to improved healthcare quality, the effectiveness of therapeutic interventions, and ultimately the health and well-being of patients.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-06-24
DOI
https://doi.org/10.7417/ct.2026.2059
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causes, clinical manifestations, and treatment efficacy of recurrent pulmonary tuberculosis.

D S Dil'magambetov, Galiya Tanzharykova, Amangeldy Zhangireyev, Kalzhan Yermekbayeva et al.
PubMed
Tuberculosis Research and Epidemiology
article

Causes, clinical manifestations, and treatment efficacy of recurrent pulmonary tuberculosis.

D S Dil'magambetov, Galiya Tanzharykova, Amangeldy Zhangireyev, Kalzhan Yermekbayeva, Altyn Almagambetova
article en

Abstract

Objective: Within the contemporary medical and scientific community, research aimed at identifying the causes, analysing the clinical manifestations, and evaluating the effectiveness of treatment for recurrent pulmonary tuberculosis has become particularly relevant considering an increasing number of cases of Mycobacterium tuberculosis (MTB) resistance to anti-tuberculosis drugs (ATDs). Methods: The study encompasses an analysis of the primary factors contributing to recurrences, including socio-economic conditions, alcohol abuse, comorbidities, incarceration, human immunodeficiency virus (HIV), and others. The morbidity structure is examined, key clinical manifestations and complications of recurrent tuberculosis are identified, and the efficacy of chemotherapy is assessed depending on the drug resistance of MTB. Statistical analysis demonstrated the percentage of successful cessation of bacterial excretion and cavity closure, as well as treatment outcomes. Results: Thus, the study represents a comprehensive analysis aimed at improving the understanding of the dynamics and factors of recurrent pulmonary tuberculosis, which is crucial for the development of more effective treatment. Conclusions: The study holds practical value for healthcare professionals, as it provides data and observations that can be utilised to enhance strategies for the diagnosis, treatment, and prevention of the disease, thereby contributing to improved healthcare quality, the effectiveness of therapeutic interventions, and ultimately the health and well-being of patients.

PubMedVol. 177(4)
West Kazakhstan Marat Ospanov State Medical University (KZ)
Good health and well-being
Openalex Percentile: Top 7%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.